(billion yen)

	FYE 3/'19	FYE 3/'20	FYE 3/'21 (guidance)
Cardiac and Vascular Company	328.5	350.6	319.0
General Hospital Company	165.8	171.0	173.0
Blood and Cell Technologies Company	105.0	107.2	108.0
Adjustments	0.2	0.2	-
Total	599.5	628.9	600.0

※Terumo Corporation has adopted IFRS from the fiscal year ended March 31, 2018.